IFI	Invasive fungal infections
IC	Invasive candidiasis
IMI	Invasive mold infection
IA	Invasive aspergillosis
OI	Opportunistic infection
PJP	Pneumocystis irovecii pneumonia
HCT	Hematopoetic Cell Transplantation
BiTE	Bispecific T-cell Engagers
BTK	Bruton’s Tyrosine Kinase
PI3K	Phosphoinositide 3-kinase
JAK	Janus-associated Kinase
BCL-2	B-cell lymphoma 2
MAb	Monoclonal antibody
NHL	Non-Hodgkin’s lymphoma
HL	Hodgkin’s lymphoma
CLL	Chronic lymphocytic leukemia
WM	Waldenstrom’s macroglobulinemia
fL	Follicular lymphoma
HGG	Hypogammaglobulinemia
DLBCL	Diffuse large B-cell lymphoma
RCT	Randomized controlled trial
R-C	Rituximab + chemotherapy
C	Standard chemotherapy
RR	Relative risk
AE	Adverse event
EORTC/MSG	European Organization for Research and Treatment of Cancer/Mycoses Study Group
NK	Natural killer cell
SLAMF7	Signaling lymphocytic activation molecule family member 7
ALL	Acute lymphoblastic leukemia
MCL	Mantle cell lymphoma
MZL	Marginal zone lymphoma
CNS	Central nervous system
PCNSL	Primary central nervous system lymphoma
CYP3A4	Cytochrome P450 3A4
AML	Acute myeloid leukemia
ADC	Antibody-drug conjugate
FLT3	FMS-like tyrosine kinase 3